BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 310.20
-7.00 (-2.21%)
Nov 2, 2026, 5:29 PM CET
BioArctic AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 27,522 | 27,550 | 17,634 | 23,651 | 23,972 | 10,497 | |
Market Cap Growth | 4.90% | 56.23% | -25.44% | -1.34% | 128.37% | 24.95% |
Enterprise Value | 25,623 | 25,714 | 17,086 | 22,956 | 23,119 | 9,623 |
Last Close Price | 317.20 | 308.97 | 198.32 | 266.22 | 270.39 | 118.50 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 261.92 | 26.95 | - | 103.17 | - | - |
Forward PE | 50.11 | 125.07 | 164.20 | 192.66 | 75.58 | 54.39 |
PS Ratio | 28.07 | 13.78 | 68.52 | 38.39 | 104.48 | 409.02 |
PB Ratio | 13.96 | 14.01 | 19.70 | 22.60 | 30.49 | 13.31 |
P/TBV Ratio | 13.96 | 14.01 | 19.70 | 22.60 | 30.49 | 13.31 |
P/FCF Ratio | 120.41 | 19.39 | - | 78.25 | - | - |
P/OCF Ratio | 115.35 | 19.25 | - | 76.37 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 26.18 | 12.86 | 66.39 | 37.27 | 100.77 | 374.98 |
EV/EBITDA Ratio | 123.83 | - | - | 83.36 | - | - |
EV/EBIT Ratio | 133.41 | 18.79 | - | 89.34 | - | - |
EV/FCF Ratio | 112.28 | 18.10 | - | 75.95 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.05 | 0.02 | 0.06 | 0.01 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.43 | 0.03 | - | 0.02 | 1.64 | - |
Debt / FCF Ratio | 0.39 | 0.03 | - | 0.02 | - | - |
Net Debt / Equity Ratio | -0.94 | -1.09 | -0.81 | -1.06 | -1.01 | -1.06 |
Net Debt / EBITDA Ratio | - | - | 3.43 | -4.02 | 424.87 | 6.18 |
Net Debt / FCF Ratio | -8.13 | -1.51 | 2.11 | -3.66 | 17.92 | 5.75 |
Asset Turnover | 0.39 | 1.08 | 0.22 | 0.60 | 0.26 | 0.03 |
Quick Ratio | 2.97 | 4.76 | 5.65 | 9.15 | 11.47 | 8.47 |
Current Ratio | 3.99 | 4.78 | 5.75 | 9.22 | 11.58 | 8.51 |
Return on Equity (ROE) | 5.21% | 71.44% | -18.24% | 25.02% | -1.42% | -14.13% |
Return on Assets (ROA) | 4.78% | 46.39% | -12.49% | 15.71% | -0.56% | -8.97% |
Return on Invested Capital (ROIC) | 52.02% | - | -134.87% | - | - | - |
Return on Capital Employed (ROCE) | 9.20% | 66.60% | -24.50% | 24.20% | -1.00% | -17.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.38% | 3.71% | -1.00% | 0.97% | -0.05% | -1.14% |
FCF Yield | 0.83% | 5.16% | -1.94% | 1.28% | -0.18% | -1.38% |
Dividend Yield | 0.64% | 0.64% | - | - | - | - |
Buyback Yield / Dilution | -0.12% | -0.23% | -0.04% | 0.22% | -0.71% | - |
Total Shareholder Return | 0.51% | 0.42% | -0.04% | 0.22% | -0.71% | - |